» Articles » PMID: 26553697

Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension

Overview
Date 2015 Nov 11
PMID 26553697
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulmonary arterial hypertension is a devastating disease with high morbidity and mortality and limited treatment options. Recent studies have shown that pulmonary artery denervation improves pulmonary hemodynamics in an experimental model and in an early clinical trial. We aimed to evaluate the nerve distribution around the pulmonary artery, to determine the effect of radiofrequency pulmonary artery denervation on acute pulmonary hypertension induced by vasoconstriction, and to demonstrate denervation of the pulmonary artery at a histological level.

Methods And Results: Histological evaluation identified a circumferential distribution of nerves around the proximal pulmonary arteries. Nerves were smaller in diameter, greater in number, and located in closer proximity to the luminal aspect of the pulmonary arterial wall beyond the pulmonary artery bifurcation. To determine the effect of pulmonary arterial denervation acute pulmonary hypertension was induced in 8 pigs by intravenous infusion of thromboxane A2 analogue. Animals were assigned to either pulmonary artery denervation, using a prototype radiofrequency catheter and generator, or a sham procedure. Pulmonary artery denervation resulted in reduced mean pulmonary artery pressure and pulmonary vascular resistance and increased cardiac output. Ablation lesions on the luminal surface of the pulmonary artery were accompanied by histological and biochemical alteration in adventitial nerves and correlated with improved hemodynamic parameters.

Conclusions: Pulmonary artery denervation offers the possibility of a new treatment option for patients with pulmonary arterial hypertension. Further work is required to determine the long-term efficacy and safety.

Citing Articles

Shifting Paradigms in the Management of Pulmonary Hypertension.

Pradhan A, Tyagi R, Sharma P, Bajpai J, Kant S Eur Cardiol. 2025; 19:e25.

PMID: 39872419 PMC: 11770536. DOI: 10.15420/ecr.2024.11.


Pulmonary artery denervation by noninvasive stereotactic radiotherapy: a pilot study in swine models of pulmonary hypertension.

Cai X, Wei Z, Shen Y, Qian L, Cai J, Yang Y Nat Commun. 2025; 16(1):558.

PMID: 39788963 PMC: 11718002. DOI: 10.1038/s41467-025-55933-8.


Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies.

Tsai J, Malik S, Tjen-A-Looi S Life (Basel). 2024; 14(10).

PMID: 39459565 PMC: 11509317. DOI: 10.3390/life14101265.


Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.

Corboz M, Nguyen T, Stautberg A, Cipolla D, Perkins W, Chapman R J Aerosol Med Pulm Drug Deliv. 2024; 37(5):241-283.

PMID: 39388691 PMC: 11502635. DOI: 10.1089/jamp.2024.0016.


High-intensity Focused Ultrasound-A New Choice to Conduct Pulmonary Artery Denervation.

Xie Y, Yao T, Zhu X, Yang F, Fan H, Cao S J Cardiovasc Transl Res. 2024; 17(6):1353-1364.

PMID: 38971920 PMC: 11635049. DOI: 10.1007/s12265-024-10531-9.


References
1.
Chen S, Zhang F, Xu J, Xie D, Zhou L, Nguyen T . Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). J Am Coll Cardiol. 2013; 62(12):1092-1100. DOI: 10.1016/j.jacc.2013.05.075. View

2.
Ciarka A, Doan V, Velez-Roa S, Naeije R, van de Borne P . Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010; 181(11):1269-75. DOI: 10.1164/rccm.200912-1856OC. View

3.
Hameed A, Arnold N, Chamberlain J, Pickworth J, Paiva C, Dawson S . Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. J Exp Med. 2012; 209(11):1919-35. PMC: 3478928. DOI: 10.1084/jem.20112716. View

4.
Crnkovic S, Egemnazarov B, Jain P, Seay U, Gattinger N, Marsh L . NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension. Br J Pharmacol. 2014; 171(16):3895-907. PMC: 4128051. DOI: 10.1111/bph.12751. View

5.
Chen S, Zhang Y, Zhou L, Xie D, Zhang F, Jia H . Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. EuroIntervention. 2013; 9(2):269-76. DOI: 10.4244/EIJV9I2A43. View